Back to search
FDAFDA · Food and drugs·Recall number Z-1111-2013

Edwards Lifesciences Duraflo coated Femoral Cannula. Product Usage: The cannulae are intended for use in situations which require rapid femoral venous and arterial access for short-term (< 6 hours) cardiopulmonary bypass. Vessel access (venous or arterial) is left to the discretion of the physician. Extracorporeal circuit components with a Duraflo coating are intended for use in cardiopulmonary surgery when a heparin-coated blood path is desired. The femoral arterial cannulae are wire-reinforced, thin-wall cannulae.

Published April 24, 2013 · Recall initiated: March 14, 2013

Summary

FDA records medical device Class II recall Z-1111-2013, published April 24, 2013 and initiated March 14, 2013. Recalling firm: Edwards Lifesciences, LLC; Status: Terminated; Reported quantity: 379 units; Lot: Model DIIFEMII018A, Lot 59337174. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Two unsealed pouches were found at an Edwards' distribution location in Japan. Incorrectly sealed pouches may result in a sterility barrier breach.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Edwards Lifesciences, LLC
Distributor
USA Nationwide Distribution including the states of: FL, MA, MI, NY, PA, TX.
Lot
Model DIIFEMII018A, Lot 59337174
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Edwards Lifesciences Duraflo coated Femoral Cannula. Product Usage: The cannulae are intended for use in situations which require rapid femoral venous and arterial access for short-term (< 6 hours) cardiopulmonary bypass. Vessel access (venous or arterial) is left to the discretion of the physician. Extracorporeal circuit components with a Duraflo coating are intended for use in cardiopulmonary surgery when a heparin-coated blood path is desired. The femoral arterial cannulae are wire-reinforced, thin-wall cannulae. recalled?

Yes. FDA published recall Z-1111-2013 on April 24, 2013. Reported hazard: Two unsealed pouches were found at an Edwards' distribution location in Japan. Incorrectly sealed pouches may result in a sterility barrier breach.

What should I do if I have this product?

Voluntary: Firm initiated · Letter